Mylan Puerto Rico Plant Warned for Skipping Specification Testing

The FDA has warned Mylan’s Caguas, Puerto Rico, facility for current good manufacturing practice (cGMP) violations, including a lack of specification testing, for finished drug products.
Generic Line